Inflammatory pathways are implicated in pathological and normal age-related cognitive decline [25,26,27] and represent one mechanism by which obesity and APOE may interact to affect vulnerability to AD and other age-related metabolic disorders. The gene discussed is APOE; the disease is Alzheimer disease.